# Mirimus, Inc.: Form D filings

Mirimus, Inc., a biotechnology company in Cold Spring Harbor, NY, filed 3 Form D notices with the SEC in 2011. The latest, on March 2, 2011, reports $2 million sold of a $2 million offering to 2 investors.

Find out what Mirimus, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Mirimus%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Mirimus%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmirimus-inc-1506012)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Mirimus%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Mirimus%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmirimus-inc-1506012)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1 BUNGTOWN ROAD, Cold Spring Harbor, NY, 11724
- Phone: (646) 221-5960
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Not Applicable
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1506012

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 2, 2011 | New notice | $2,000,000 | $2,000,000 | $0 | 2 | Feb 17, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1506012/000150601211000003/0001506012-11-000003-index.htm) |
| Feb 11, 2011 | Amendment | $825 | $825 | $0 | 6 | Jan 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1506012/000150601211000002/0001506012-11-000002-index.htm) |
| Jan 31, 2011 | New notice | $825 | $775 | $50 | 6 | Jan 28, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1506012/000150601211000001/0001506012-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Prem Premsrirut | Executive Officer, Director |  |
| Leo Guthart | Director |  |
| John Maroney | Director |  |
| Steven Winick | Director |  |

## Other biotechnology companies in New York that filed recently

- [Swep Bio, Inc.](https://specstream.ai/data/form-d/company/swep-bio-inc-2159106) $2.5 million · Oct 29, 2026
- [Hypercell Technologies Inc.](https://specstream.ai/data/form-d/company/hypercell-technologies-inc-1882357) $3 million · Oct 14, 2026
- [CAD Therapeutics, Inc.](https://specstream.ai/data/form-d/company/cad-therapeutics-inc-2157566) $4 million · Oct 2, 2026
- [Vicora, Inc.](https://specstream.ai/data/form-d/company/vicora-inc-2091847) $2.3 million · Sep 18, 2026
- [GevRx Nutraceuticals, Inc.](https://specstream.ai/data/form-d/company/gevrx-nutraceuticals-inc-2156105) $300,000 · Sep 18, 2026
- [Episteme Prognostics, Inc.](https://specstream.ai/data/form-d/company/episteme-prognostics-inc-1902402) $5.1 million · Sep 4, 2026

[Every Form D from the week of Feb 28, 2011](https://specstream.ai/data/form-d/week/2011-02-28) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Mirimus, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).